Chemical Formula: C19H20N2O2
Chemical Formula C19H20N2O2
Found 38 metabolite its formula value is C19H20N2O2
Phenylbutazone
A drug that has anti-inflammatory, antipyretic, and analgesic activities. It is especially effective in the treatment of ankylosing spondylitis. It also is useful in rheumatoid arthritis and Reiter's syndrome (investigational indication). Although phenylbutazone is effective in gouty arthritis, risk/benefit considerations indicate that this drug should not be employed for this disease. (From AMA Drug Evaluations Annual, 1994, p1822) M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 3615 EAWAG_UCHEM_ID 3615; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 1158 D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
DMXB-A
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists
4-Butyl-5-hydroxy-1,2-diphenylpyrazol-3-one
3-(2,4-Dimethoxybenzylidene)anabaseine
18-hydroxy nor fluorocurarine|18-Hydroxynorfluorocurarine|strychnofluorine (18-hydroxynorfluorocurarine)
(20alpha)-20-methyl-15,16-didehydro-18-oxayohimban-21-one|Latifoliamide C
(5Z,6R)-1,6,7,8-tetrahydro-5-(hydroxyethylidene)-7-methylene-2H-3,6-ethanoazonino[5,4-b]indol-4(5H)-one|pericidine
N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]pyridine-3-carboxamide
phenylbutazone
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AA - Butylpyrazolidines A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
1H-(Indol-3-yl)-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline
Vincanidine
Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids Annotation level-1
(11S,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo(9.5.2.0(1,9).0(2,7).0(14,17))octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; Origin: Plant; PRIME Parent Name:Vincanidine; PRIME in-house No.:V0312; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids PRIME in-house No.:V0312; Origin: Plant; Formula(Parent): C19H20N2O2; Bottle Name:Vincanidine; PRIME Parent Name:Vincanidine; SubCategory_DNP: Monoterpenoid indole alkaloids, Aspidosperma alkaloids, Indole alkaloids
UK-156819
CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4744; ORIGINAL_PRECURSOR_SCAN_NO 4743 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3450; ORIGINAL_PRECURSOR_SCAN_NO 3448 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3446; ORIGINAL_PRECURSOR_SCAN_NO 3443 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3439; ORIGINAL_PRECURSOR_SCAN_NO 3437 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3452; ORIGINAL_PRECURSOR_SCAN_NO 3448 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4773; ORIGINAL_PRECURSOR_SCAN_NO 4772 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7655; ORIGINAL_PRECURSOR_SCAN_NO 7653 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7663; ORIGINAL_PRECURSOR_SCAN_NO 7661 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7644; ORIGINAL_PRECURSOR_SCAN_NO 7642 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7660; ORIGINAL_PRECURSOR_SCAN_NO 7658 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7675; ORIGINAL_PRECURSOR_SCAN_NO 7673 CONFIDENCE standard compound; INTERNAL_ID 836; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7714; ORIGINAL_PRECURSOR_SCAN_NO 7712
N-[2-(5-methoxy-2-phenyl-1H-indol-3-yl)ethyl]acetamide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
3-[(2,5-dimethylanilino)methyl]-6-methoxy-1H-quinolin-2-one
12-Ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
(1R,11S,12E,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
1-(1H-indol-3-yl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline
(1R,11R,12E,17S)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
(12Z)-12-ethylidene-6-hydroxy-8,14-diazapentacyclo[9.5.2.01,9.02,7.014,17]octadeca-2(7),3,5,9-tetraene-10-carbaldehyde
3-(2,4-Dimethoxybenzylidene)anabaseine
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists